Oxitropium

DB12086InvestigationalSmall molecule

Oxitropium has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

Chemical structure of Oxitropium
Formula / weight
C19H26NO4 · 332.419 g/mol (avg)

Resolves to

Compound
UNII8G15T83E6ICAS99571-64-9ChEBI135418PubChem6917866
Clinical / RWD
RxNorm32649ATCR03BB02
Structure
InChIKeyNVOYVOBDTVTBDX-PMEUIYRNSA-NSMILESCC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Targets
P08912CHRM5

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
516Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxitropium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In